© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Background: Predicting progression from Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) is an utmost open issue in AD-related rese...
Background: Available therapies for Alzheimer's disease (AD) can only alleviate and delay the advanc...
Background: Diagnosis of Alzheimer's disease (AD) confirmed by biomarkers allows the patient to make...
Alzheimer’s Disease (AD) represents the most frequent (60-80%) subtype of dementia and is one kind o...
Background Predicting progression from Mild Cognitive Impairment (MCI) to Alzheimer...
Background: Despite the increasing availability in brain health related data, clinically translatabl...
International audienceWe performed a systematic review of studies focusing on the automatic predicti...
In Alzheimer’s disease (AD) progression, it is imperative to identify the subjects with mild cogniti...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer’s d...
BACKGROUND: This study investigates the prediction of mild cognitive impairment-to-Alzheimer's disea...
Background: Alzheimer’s disease (AD) is a neurodegenerative condition driven by multifactorial etiol...
Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer’s disease (AD). Ea...
BackgroundPredicting clinical course of cognitive decline can boost clinical trials' power and impro...
According to the World Health Organization forecast, over 55 million people worldwide have dementia...
Cognitive scores are the most common measures in diagnosing Alzheimer’s disease which are measured c...
Background: Predicting progression from a stage of Mild Cognitive Impairment to dementia is a major ...
Background: Available therapies for Alzheimer's disease (AD) can only alleviate and delay the advanc...
Background: Diagnosis of Alzheimer's disease (AD) confirmed by biomarkers allows the patient to make...
Alzheimer’s Disease (AD) represents the most frequent (60-80%) subtype of dementia and is one kind o...
Background Predicting progression from Mild Cognitive Impairment (MCI) to Alzheimer...
Background: Despite the increasing availability in brain health related data, clinically translatabl...
International audienceWe performed a systematic review of studies focusing on the automatic predicti...
In Alzheimer’s disease (AD) progression, it is imperative to identify the subjects with mild cogniti...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer’s d...
BACKGROUND: This study investigates the prediction of mild cognitive impairment-to-Alzheimer's disea...
Background: Alzheimer’s disease (AD) is a neurodegenerative condition driven by multifactorial etiol...
Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer’s disease (AD). Ea...
BackgroundPredicting clinical course of cognitive decline can boost clinical trials' power and impro...
According to the World Health Organization forecast, over 55 million people worldwide have dementia...
Cognitive scores are the most common measures in diagnosing Alzheimer’s disease which are measured c...
Background: Predicting progression from a stage of Mild Cognitive Impairment to dementia is a major ...
Background: Available therapies for Alzheimer's disease (AD) can only alleviate and delay the advanc...
Background: Diagnosis of Alzheimer's disease (AD) confirmed by biomarkers allows the patient to make...
Alzheimer’s Disease (AD) represents the most frequent (60-80%) subtype of dementia and is one kind o...